$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Venous Thromboembolism in Patients with Advanced Pancreatic Cancer Receiving Palliative Chemotherapy: Incidence and Effect on Prognosis 원문보기

대한소화기학회지 = The Korean journal of gastroenterology, v.81 no.3, 2023년, pp.109 - 120  

Jeong, Han Taek (Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea) ,  Bae, June Hwa (Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea) ,  Kim, Ho Gak (Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea) ,  Han, Jimin (Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea)

초록이 없습니다.

참고문헌 (32)

  1. Sung, Hyuna, Ferlay, Jacques, Siegel, Rebecca L., Laversanne, Mathieu, Soerjomataram, Isabelle, Jemal, Ahmedin, Bray, Freddie. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, vol.71, no.3, 209-249.

  2. Jung, Kyu-Won, Won, Young-Joo, Kang, Mee Joo, Kong, Hyun-Joo, Im, Jeong-Soo, Seo, Hong Gwan. Prediction of Cancer Incidence and Mortality in Korea, 2022. Cancer research and treatment : official journal of Korean Cancer Association, vol.54, no.2, 345-351.

  3. Sung, Min Je, Bang, Seungmin. Updates of Chemotherapy and Radiotherapy for Pancreatic Cancer. The Korean journal of pancreas and biliary tract = 대한췌담도학회지, vol.25, no.2, 72-82.

  4. Frere, Corinne. Burden of venous thromboembolism in patients with pancreatic cancer. World journal of gastroenterology : WJG, vol.27, no.19, 2325-2340.

  5. Berger, Anne Katrin, Singh, Hans Martin, Werft, Wiebke, Muckenhuber, Alexander, Sprick, Martin R., Trumpp, Andreas, Weichert, Wilko, Jäger, Dirk, Springfeld, Christoph. High prevalence of incidental and symptomatic venous thromboembolic events in patients with advanced pancreatic cancer under palliative chemotherapy: A retrospective cohort study. Pancreatology : official journal of the International Association of Pancreatology ... [et al.], vol.17, no.4, 629-634.

  6. Lyman, Gary H., Eckert, Laurent, Wang, Yanxin, Wang, Hongwei, Cohen, Alexander. Venous Thromboembolism Risk in Patients With Cancer Receiving Chemotherapy: A Real-World Analysis. The oncologist, vol.18, no.12, 1321-1329.

  7. García Adrián, Silvia, González, Adán Rodríguez, de Castro, Eva Martínez, Olmos, Vanessa Pachón, Morán, Laura Ortega, del Prado, Purificación Martínez, Fernández, Mercedes Salgado, Burón, José David Cumplido, Escobar, Ignacio García, Galán, Joaquina Martínez, Pérez, Ana Isabel Ferrer, Neria, Fernando, Lavin, Diego Cacho, Hernández, Borja López de San Vicente, Jiménez-Fonseca, Paula, Muñoz Martín, Andrés J.. Incidence, risk factors, and evolution of venous thromboembolic events in patients diagnosed with pancreatic carcinoma and treated with chemotherapy on an outpatient basis. European journal of internal medicine, vol.105, 30-37.

  8. Hanna-Sawires, Randa G., Groen, Jesse V., Hamming, Alexander, Tollenaar, Rob A.E.M., Mesker, Wilma E., Luelmo, Saskia A.C., Vahrmeijer, Alexander L., Bonsing, Bert A., Versteeg, Henri H., Klok, F.A., Mieog, J.Sven D.. Incidence, timing and risk factors of venous thromboembolic events in patients with pancreatic cancer. Thrombosis research, vol.207, 134-139.

  9. Barrau, Mathilde, Maoui, Khawla, Le Roy, Bertrand, Roblin, Xavier, Mismetti, Patrick, Phelip, Jean-Marc, Williet, Nicolas. Early venous thromboembolism is a strong prognostic factor in patients with advanced pancreatic ductal adenocarcinoma. Journal of cancer research and clinical oncology, vol.147, no.11, 3447-3454.

  10. Kruger, S., Haas, M., Burkl, C., Goehring, P., Kleespies, A., Roeder, F., Gallmeier, E., Ormanns, S., Westphalen, C.B., Heinemann, V., Rank, A., Boeck, S.. Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer - A retrospective cohort study. Thrombosis research, vol.157, 9-15.

  11. Suzuki, Takahito, Hori, Reina, Takeuchi, Kazutaka, Yamamura, Ryo, Katoh, Hiromasa, Noji, Yoshihiro, Yamaguchi, Masato, Fujino, Susumu. Venous Thromboembolism in Japanese Patients With Pancreatic Cancer. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, vol.27, 10760296211051766-.

  12. Yoon, Seug Yun, Lee, Min-Young, Yoon, Jina, Kim, Han Jo, Kim, Kyoung-Ha, Kim, Se Hyung, Lee, Sang-Cheol, Bae, Sang Byung, Kim, Chan-Kyu, Lee, Nam-Su, Lee, Kyu Taek, Park, Sung Kyu, Hong, Dae Sik, Won, Jong-Ho. The incidence of venous thromboembolism is not lowin Korean patients with advanced pancreatic cancer. Blood research, vol.53, no.3, 227-232.

  13. Chen, Jen-Shi, Hung, Chia-Yen, Chang, Hung, Liu, Chien-Ting, Chen, Yen-Yang, Lu, Chang-Hsien, Chang, Pei-Hung, Hung, Yu-Shin, Chou, Wen-Chi. Venous Thromboembolism in Asian Patients with Pancreatic Cancer Following Palliative Chemotherapy: Low Incidence but a Negative Prognosticator for Those with Early Onset. Cancers, vol.10, no.12, 501-.

  14. Lee, Jong-Chan, Ro, Young Sun, Cho, Junhyeon, Park, Yohan, Lee, Ji Hye, Hwang, Jin-Hyeok, Choi, Hye Jin, Lee, Soohyeon. Characteristics of Venous Thromboembolism in Pancreatic Adenocarcinoma in East Asian Ethnics : A Large Population-Based Observational Study. Medicine, vol.95, no.17, e3472-.

  15. Oh, S.Y., Kim, J.H., Lee, K.W., Bang, S.M., Hwang, J.H., Oh, D., Lee, J.S.. Venous thromboembolism in patients with pancreatic adenocarcinoma: Lower incidence in Asian ethnicity. Thrombosis research, vol.122, no.4, 485-490.

  16. Yamai, Takuo, Ikezawa, Kenji, Hiraga, Erika, Kawamoto, Yasuharu, Hirao, Takeru, Higashi, Sena, Daiku, Kazuma, Maeda, Shingo, Abe, Yutaro, Urabe, Makiko, Kai, Yugo, Takada, Ryoji, Nakabori, Tasuku, Fukutake, Nobuyasu, Uehara, Hiroyuki, Fujita, Masashi, Ohkawa, Kazuyoshi. Early detection of venous thromboembolism after the initiation of chemotherapy predicts a poor prognosis in patients with unresectable metastatic pancreatic cancer who underwent first-line chemotherapy with gemcitabine plus nab-paclitaxel. PLoS ONE, vol.17, no.3, e0264653-.

  17. Pancreatic Adenocarcionma (Version 1. 2022). 2022 [Internet]. Plymouth Meeting (PA): National Comprehensive Cancer Network; 2022 [cited 2022 Nov 2]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf. 

  18. Khorana, Alok A., Kuderer, Nicole M., Culakova, Eva, Lyman, Gary H., Francis, Charles W.. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood, vol.111, no.10, 4902-4907.

  19. CME Exam 4: Incidence of Venous Thromboembolism in Patients with Newly Diagnosed Pancreatic Cancer and Factors Associated with Outcomes. Gastroenterology, vol.158, no.5, e19-e19.

  20. Hisada, Yohei, Mackman, Nigel. Cancer-associated pathways and biomarkers of venous thrombosis. Blood, vol.130, no.13, 1499-1506.

  21. 10.2174/1566524011313030003 

  22. Mattila, N., Hisada, Y., Przybyla, B., Posma, J., Jouppila, A., Haglund, C., Seppänen, H., Mackman, N., Lassila, R.. Levels of the cancer biomarker CA 19-9 are associated with thrombin generation in plasma from treatment-naïve pancreatic cancer patients. Thrombosis research, vol.199, 21-31.

  23. Hanna, Kamil, Khalid, Aizaz, Hamidi, Mohammad, Gries, Lynn, Haddadin, Zaid, Kulvatunyou, Narong, Zeeshan, Muhammad, Joseph, Bellal. Chronic Alcohol Consumption and Risk of Deep Venous Thrombosis: A Propensity-Matched Analysis. The Journal of surgical research, vol.244, 251-256.

  24. Pomp, Elisabeth R, Rosendaal, Frits R, Doggen, Carine J. M. Alcohol consumption is associated with a decreased risk of venous thrombosis. Thrombosis and haemostasis, vol.99, no.1, 59-63.

  25. Gaborit, Freja, Overvad, Kim, Nørgaard, Mette, Kristensen, Søren, Tjønneland, Anne, Severinsen, Marianne. Alcohol intake and risk of venous thromboembolism : A Danish follow-up study. Thrombosis and haemostasis, vol.110, no.1, 39-45.

  26. Mukamal, Kenneth J., Jadhav, Praveen P., D’Agostino, Ralph B., Massaro, Joseph M., Mittleman, Murray A., Lipinska, Izabella, Sutherland, Patrice A., Matheney, Travis, Levy, Daniel, Wilson, Peter W.F., Ellison, R. Curtis, Silbershatz, Halit, Muller, James E., Tofler, Geoffrey H.. Alcohol Consumption and Hemostatic Factors : Analysis of the Framingham Offspring Cohort. Circulation, vol.104, no.12, 1367-1373.

  27. Ouaissi, M., Frasconi, C., Mege, D., Panicot-dubois, L., Boiron, L., Dahan, L., Debourdeau, P., Dubois, C., Farge, D., Sielezneff, I.. Impact of venous thromboembolism on the natural history of pancreatic adenocarcinoma. Hepatobiliary & pancreatic diseases international : HBPD INT, vol.14, no.4, 436-442.

  28. Conroy, Thierry, Desseigne, Françoise, Ychou, Marc, Bouché, Olivier, Guimbaud, Rosine, Bécouarn, Yves, Adenis, Antoine, Raoul, Jean-Luc, Gourgou-Bourgade, Sophie, de la Fouchardière, Christelle, Bennouna, Jaafar, Bachet, Jean-Baptiste, Khemissa-Akouz, Faiza, Péré-Vergé, Denis, Delbaldo, Catherine, Assenat, Eric, Chauffert, Bruno, Michel, Pierre, Montoto-Grillot, Christine, Ducreux, Michel. FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer. The New England journal of medicine, vol.364, no.19, 1817-1825.

  29. Kwon, Hyuk-Chan, Oh, Sung Yong, Lee, Suee, Kim, Sung-Hyun, Han, Jin Yeong, Koh, Ri Young, Kim, Min Chan, Kim, Hyo-Jin. Plasma levels of prothrombin fragment F1+2, D-dimer and prothrombin time correlate with clinical stage and lymph node metastasis in operable gastric cancer patients.. Japanese journal of clinical oncology, vol.38, no.1, 2-7.

  30. Wang, Xue-Ping, Mao, Min- Jie, He, Zhong-Lian, Zhang, Lin, Chi, Pei-Dong, Su, Jia-rui, Dai, Shu-Qin, Liu, Wan-Li. A retrospective discussion of the prognostic value of combining prothrombin time(PT) and fibrinogen(Fbg) in patients with Hepatocellular carcinoma. Journal of Cancer, vol.8, no.11, 2079-2087.

  31. Pelzer, Uwe, Opitz, Bernhard, Deutschinoff, Gerd, Stauch, Martina, Reitzig, Peter C., Hahnfeld, Sabine, Müller, Lothar, Grunewald, Martina, Stieler, Jens M., Sinn, Marianne, Denecke, Timm, Bischoff, Sven, Oettle, Helmut, Dörken, Bernd, Riess, Hanno. Efficacy of Prophylactic Low–Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.33, no.18, 2028-2034.

  32. Maraveyas, A., Waters, J., Roy, R., Fyfe, D., Propper, D., Lofts, F., Sgouros, J., Gardiner, E., Wedgwood, K., Ettelaie, C., Bozas, G.. Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer. European journal of cancer, vol.48, no.9, 1283-1292.

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로